- Joined
- May 23, 2015
- Messages
- 35
- Reaction score
- 9
Hey everyone,
I'm taking over an esketamine/Spravato clinic at our academic center and was looking to ask for some advice. For those who've worked or are currently working in esketamine/ketamine clinic, what PRN meds (if at all) do you use for hypertension or tachycardia?
At my institution we have the following scenarios and treatments delineated:
SCENARIOS
Scenario 1 (hypertension): BP > 180/110 on two separate measurements 5min apart OR BP > 200/120 on any single measurement
Scenario 2 (tachycardia): Sustained HR > 120min for 5min
Scenario 3 (borderline HR): HR < 70
CURRENT PRN TREATMENT
Scenario 1 AND/OR Scenario 2: Metoprolol tartrate 50 mg tab
Scenario 1 AND Scenario 3: Diltiazem 30 mg tab
Now this seemed a bit strange to me, as I was generally taught that you don't intervene for blood pressure or tachycardia from esketamine unless they're symptomatic (headache, changes to hearing vision, ataxia/vertigo, etc.
Any thoughts on what could be be better substitutes for PRN treatments in the above scenarios? I've come up with the below.
PROPOSED PRN TREATMENT
Scenario 1 ONLY: Clonidine 0.1 mg tab (if contraindicated then hydralazine 25 mg tab)
Scenario 2 ONLY: Metoprolol tartrate 50 mg tab (if contraindicated then diltiazem 30 mg tab)
Scenario 2 AND Scenario 1: Metoprolol tartrate 50 mg tab (if contraindicated then diltiazem 30 mg tab)
Scenario 1 AND Scenario 3: Hydralazine 25 mg tab (if contraindicated then prazosin 2 mg tab)
Any feedback or input would be greatly appreciated. I'm still very green to this and the literature search I've done hasn't produced much except for the below which recommended IV hydralazine/PO clonidine for hypertension and labetalol for tachycardia.
pmc.ncbi.nlm.nih.gov
pmc.ncbi.nlm.nih.gov
I'm taking over an esketamine/Spravato clinic at our academic center and was looking to ask for some advice. For those who've worked or are currently working in esketamine/ketamine clinic, what PRN meds (if at all) do you use for hypertension or tachycardia?
At my institution we have the following scenarios and treatments delineated:
SCENARIOS
Scenario 1 (hypertension): BP > 180/110 on two separate measurements 5min apart OR BP > 200/120 on any single measurement
Scenario 2 (tachycardia): Sustained HR > 120min for 5min
Scenario 3 (borderline HR): HR < 70
CURRENT PRN TREATMENT
Scenario 1 AND/OR Scenario 2: Metoprolol tartrate 50 mg tab
Scenario 1 AND Scenario 3: Diltiazem 30 mg tab
Now this seemed a bit strange to me, as I was generally taught that you don't intervene for blood pressure or tachycardia from esketamine unless they're symptomatic (headache, changes to hearing vision, ataxia/vertigo, etc.
Any thoughts on what could be be better substitutes for PRN treatments in the above scenarios? I've come up with the below.
PROPOSED PRN TREATMENT
Scenario 1 ONLY: Clonidine 0.1 mg tab (if contraindicated then hydralazine 25 mg tab)
Scenario 2 ONLY: Metoprolol tartrate 50 mg tab (if contraindicated then diltiazem 30 mg tab)
Scenario 2 AND Scenario 1: Metoprolol tartrate 50 mg tab (if contraindicated then diltiazem 30 mg tab)
Scenario 1 AND Scenario 3: Hydralazine 25 mg tab (if contraindicated then prazosin 2 mg tab)
Any feedback or input would be greatly appreciated. I'm still very green to this and the literature search I've done hasn't produced much except for the below which recommended IV hydralazine/PO clonidine for hypertension and labetalol for tachycardia.
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability - PMC
Racemic ketamine, a derivative of phencyclidine, has been used as a dissociative anesthetic since 1970. In 2000, the first randomized controlled trial showed a rapid relief of depressive symptoms. Since then, intravenous ketamine and intranasal ...

A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression - PMC
The strategy of repeated ketamine in open-label and saline-control studies of treatment-resistant depression suggested greater antidepressant response beyond a single ketamine. However, consensus guideline stated the lack of evidence to support ...
